W przypadku konieczności uwzględnienia we wniosku informacji związanych z charakterystyką Uniwersytetu Medycznego w Białymstoku, zachęcamy do zapoznania się z tabelą zamieszczoną poniżej i dostosowanie jej do treści Państwa wniosku.
Legal Name | Uniwersytet Medyczny w Białymstoku (Medical University of Bialystok – MUB) |
Country | Poland |
General description
| The MUB is a modern, dynamically growing public university with a mission to serve the society through innovative education of professional medical staff, conducting scientific research, development and implementation work at the highest international level, and the development of clinical activities in line with the progress of medical knowledge. The MUB contributes to large-scale research on genomics, proteomics, metabolomics, radiomics, and bioinformatics. In the course of implementing unique research projects in the field of personalised medicine and lifestyle diseases, we have built a database, remarkable in the European scale, containing the results of whole genome sequecing (WGS) of several hundred patients with oncological and other lifestyle diseases. The MUB pioneers in the field of advanced banking of biological material from patients with lifestyle diseases. The collected data is fed to the Polish HD Medicine Database, designed as a source of in-depth understanding of the mechanisms of such health concerns as cancer, cardiovascular diseases, metabolic diseases and more, and as groundwork for the development of new therapeutic applications. |
Key Persons and Expertise (including supervisors) | Names of Team Leader and Team Members |
Key Research Facilities, Infrastructure and Equipment
| The MUB has an ultra-modern research and teaching base, which includes, i.e., 2 University Clinical Hospitals, Euroregional Pharmacy Centre, Didactic and Scientific Centre of the Faculty of Health Sciences, Clinical Research Centre, Experimental Medicine Centre, Innovative Research Centre, Centre for Bioinformatics and Data Analysis, Molecular Imaging Laboratory, Centre for Medical Simulation, and Centre of Artificial Intelligence. |
Previous and Current Involvement in Research and Training Programmes
| Many EU research and training projects funded, including 3 H2020 (1 MSCA COFUND): ImPRESS 754432, JoinUs4Health 101006518, VACCELERATE 1101037867, from the ERASMUS+ programme: BECOMING, AccLifeSci, PRECISEMED; other projects funded within European Joint Programmes: e.g. Rare Diseases Joint Transnational Call ProgerOmics or M-ERA.NET SMARTGEL. e.g., cofinanced under the Polish National Agency for Academic Exchange 'Strategic Partnerships' programme ('Monoclonal antibodies in combination with thiazolidinone analogs as a modern anticancer strategy'). |